Securities code: 000078 securities abbreviation: Shenzhen Neptunus Bioengineering Co.Ltd(000078) Announcement No.: 2021-076 Shenzhen Neptunus Bioengineering Co.Ltd(000078)
Progress announcement on the transfer of accounts receivable of some subsidiaries
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Transaction overview
Shenzhen Neptunus Bioengineering Co.Ltd(000078) (hereinafter referred to as “the company”) deliberated and adopted the proposal on transferring part of the accounts receivable of subsidiaries at the 20th meeting of the eighth board of directors held on May 28, 2021. The board of directors unanimously agreed that the company would transfer the accounts receivable of about 2.1 billion yuan held by subsidiaries to Changchun Gantong Trade Co., Ltd. at a consideration of 1.988.7 billion yuan Changchun Jinyi Medical Instrument Co., Ltd. For details, please refer to the announcement on the transfer of some accounts receivable of subsidiaries published by the company in the securities times, China Securities Journal, Shanghai Securities News and cninfo.com on May 29, 2021.
2、 Transaction progress
As of the disclosure date of this announcement, the company has received the total transfer price of RMB 1988.7 million, and the transaction has been completed.
It is hereby announced.
Shenzhen Neptunus Bioengineering Co.Ltd(000078) board of directors
December 31, 2001
